What is a Pragmatic Clinical Trial
Section 5
Key Considerations for PCTs
Contributors
Contributing Editors
Karen Staman, MS
Jonathan McCall, MS
Liz Wing, MA
PCTs require different approaches to study design, start-up, conduct, oversight, review, and dissemination than traditional RCTs, although the current ethical, regulatory, and logistical systems were created with the more “traditional” RCT in mind (O’Rourke et al. 2015). To provide expertise to the NIH Collaboratory Demonstration Projects, several working groups, or Cores, were created to explore key elements of PCTs: electronic health records; phenotypes, data standards and data quality; patient-reported outcomes; health care systems interactions; ethics and regulatory; biostatistics and study design; and stakeholder engagement. In this textbook, we use information provided by the NIH Collaboratory Cores, Demonstration Projects, and the literature to explore these considerations for PCTs. We invite you to navigate through each section sequentially or by using the navigation menu to select a topic of interest.
SECTIONS
REFERENCES
O’Rourke PP, Carrithers J, Patrick-Lake B, et al. 2015. Harmonization and streamlining of research oversight for pragmatic clinical trials. Clin Trials. 12:449–456. doi:10.1177/1740774515597685. PMID: 26374678.